740 Pattern of natural killer (NK) cell (CD16+CD56+) expansion correlates with response outcomes with nemvaleukin alfa treatment

• Omid Hamid,
• Vamsidhar Velcheti,
• David F McDermott,
• Marc S Ernstoff,
• John L Hays,
• Yangchun Du,
• Sonali Panchabhai,
• Sarah Donatelli,
• Daniel G Smith,
• Ulka N Vaishampayan

Affiliations

Omid Hamid

3The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA, USA

Vamsidhar Velcheti

6New York University, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA

David F McDermott

5Beth Israel Deaconess Medical Center, Boston, MA, USA

Marc S Ernstoff

2NCI Division of Cancer Treatment and Diagnosis, Developmental Therapy Program, Bethesda, MD, USA

John L Hays

4Wexner Medical Center and The James Cancer Hospital, Ohio State University, Columbus, OH, USA

Yangchun Du

1Alkermes, Inc., Waltham, MA, USA

Sonali Panchabhai

1Alkermes, Inc., Waltham, MA, USA

Sarah Donatelli

1Alkermes, Inc., Waltham, MA, USA

Daniel G Smith

7Alkermes, Waltham, MA, USA

Ulka N Vaishampayan

8Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA